Skip to main content
Erschienen in: European Radiology 5/2014

01.05.2014 | Head and Neck

Magnetic resonance imaging with diffusion-weighted imaging in the evaluation of thyroid-associated orbitopathy: getting below the tip of the iceberg

verfasst von: Letterio Salvatore Politi, Claudia Godi, Gabriella Cammarata, Alessandro Ambrosi, Antonella Iadanza, Roberto Lanzi, Andrea Falini, Stefania Bianchi Marzoli

Erschienen in: European Radiology | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To compare extraocular muscles (EOMs) T2, post-contrast T1 (T1Gad) signal intensity ratios (SIRs) and normalized-apparent diffusion coefficient (n-ADC) values in patients with thyroid-associated orbitopathy (TAO) at different phases of activity and severity and correlate MRI modifications to clinical evolution during follow-up.

Methods

A total of 74 TAO patients were classified as active or inactive on the basis of the clinical activity score (CAS). Severity of EOM impairment was evaluated by assigning a functional score to each rectus. T2, T1Gad SIRs and n-ADC of EOMs were compared in patients with active inflammation, those with inactive disease and 26 healthy controls, and correlated with clinical scores. MRI parameter variation was correlated with clinical modifications during follow-up.

Results

All MRI parameters in TAO EOMs were significantly higher than in healthy subjects and correlated with muscle dysfunction and CAS. EOMs of active patients showed higher T2 and T1Gad SIRs than those with inactive disease. The T2 SIR and n-ADC of normally functioning TAO EOMs were higher than those of healthy controls. SIRs decreased in clinically improved and clinically stable EOMs after therapy.

Conclusions

T2 SIR, T1Gad SIR and n-ADC are objective measures of activity and severity of EOMs in TAO patients. MRI shows clinically silent muscle involvement and modifications.

Key Points

MRI and DWI measures are objective, quantitative parameters of TAO activity and severity
MRI and DWI measures significantly correlate with clinical scores in TAO patients
MRI and DWI can identify clinically silent inflammation of deep orbital structures
MRI and DWI can depict subclinical modifications during follow-up
MRI and DWI may aid clinicians in choosing the most appropriate treatment
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Dickinson AJ, Perros P (2001) Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment. Clin Endocrinol (Oxf) 55:283–303CrossRef Dickinson AJ, Perros P (2001) Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment. Clin Endocrinol (Oxf) 55:283–303CrossRef
3.
Zurück zum Zitat Parmar H, Ibrahim M (2008) Extrathyroidal manifestations of thyroid disease: thyroid ophthalmopathy. Neuroimaging Clin N Am 18:527–536PubMedCrossRef Parmar H, Ibrahim M (2008) Extrathyroidal manifestations of thyroid disease: thyroid ophthalmopathy. Neuroimaging Clin N Am 18:527–536PubMedCrossRef
4.
Zurück zum Zitat El-Kaissi S, Frauman AG, Wall JR (2004) Thyroid-associated ophthalmopathy: a practical guide to classification, natural history and management. Intern Med J 34:482–491PubMedCrossRef El-Kaissi S, Frauman AG, Wall JR (2004) Thyroid-associated ophthalmopathy: a practical guide to classification, natural history and management. Intern Med J 34:482–491PubMedCrossRef
5.
Zurück zum Zitat Carl A, Pedersen IB, Knudsen N et al (2011) Epidemiology of subtypes of hyperthyroidism in Denmark: a population-based study. Eur J Endocrinol 164:801–809CrossRef Carl A, Pedersen IB, Knudsen N et al (2011) Epidemiology of subtypes of hyperthyroidism in Denmark: a population-based study. Eur J Endocrinol 164:801–809CrossRef
6.
Zurück zum Zitat Abraham-Nordling M, Bystrom K, Torring O et al (2011) Incidence of hyperthyroidism in Sweden. Eur J Endocrinol 165:899–905PubMedCrossRef Abraham-Nordling M, Bystrom K, Torring O et al (2011) Incidence of hyperthyroidism in Sweden. Eur J Endocrinol 165:899–905PubMedCrossRef
7.
Zurück zum Zitat Eckstein A, Schittkowski M, Esser J (2012) Surgical treatment of Graves' ophthalmopathy. Best Pract Res Clin Endocrinol Metab 26:339–358PubMedCrossRef Eckstein A, Schittkowski M, Esser J (2012) Surgical treatment of Graves' ophthalmopathy. Best Pract Res Clin Endocrinol Metab 26:339–358PubMedCrossRef
8.
Zurück zum Zitat Soeters M, van Zeijl C, Boelen A et al (2011) Optimal management of Graves orbitopathy: a multidisciplinary approach. Neth J Med 69:302–308PubMed Soeters M, van Zeijl C, Boelen A et al (2011) Optimal management of Graves orbitopathy: a multidisciplinary approach. Neth J Med 69:302–308PubMed
9.
Zurück zum Zitat Boboridis K, Bunce C (2011) Surgical orbital decompression for thyroid eye disease. Cochrane Database Syst Rev CD007630 Boboridis K, Bunce C (2011) Surgical orbital decompression for thyroid eye disease. Cochrane Database Syst Rev CD007630
10.
Zurück zum Zitat Mourits M, Koornneef L, Wiersinga W, Prummel M, Berghout A, van der Gaag R (1989) Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. Br J Ophthalmol 73:639–644PubMedCentralPubMedCrossRef Mourits M, Koornneef L, Wiersinga W, Prummel M, Berghout A, van der Gaag R (1989) Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. Br J Ophthalmol 73:639–644PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Hosten N, Sander B, Cordes M, Schubert CJ, Schorner W, Felix R (1989) Graves ophthalmopathy: MR imaging of the orbits. Radiology 172:759–762PubMed Hosten N, Sander B, Cordes M, Schubert CJ, Schorner W, Felix R (1989) Graves ophthalmopathy: MR imaging of the orbits. Radiology 172:759–762PubMed
12.
Zurück zum Zitat Sillaire I (2003) Graves' ophthalmopathy: usefulness of T2 weighted muscle signal intensity. J Radiol 84:139–142PubMed Sillaire I (2003) Graves' ophthalmopathy: usefulness of T2 weighted muscle signal intensity. J Radiol 84:139–142PubMed
13.
Zurück zum Zitat Prummel MF, Gerding MN, Zonneveld FW, Wiersinga WM (2001) The usefulness of quantitative orbital magnetic resonance imaging in Graves' ophthalmopathy. Clin Endocrinol 54:205–209CrossRef Prummel MF, Gerding MN, Zonneveld FW, Wiersinga WM (2001) The usefulness of quantitative orbital magnetic resonance imaging in Graves' ophthalmopathy. Clin Endocrinol 54:205–209CrossRef
14.
Zurück zum Zitat Taoka T, Iwasaki S, Uchida H (2000) Enhancement pattern of normal extraocular muscles in dynamic contrast-enhancement MR imaging with suppression. Acta Radiol 41:211–216PubMedCrossRef Taoka T, Iwasaki S, Uchida H (2000) Enhancement pattern of normal extraocular muscles in dynamic contrast-enhancement MR imaging with suppression. Acta Radiol 41:211–216PubMedCrossRef
15.
Zurück zum Zitat Taoka T (2005) Evaluation of extraocular muscles using dynamic contrast enhanced MRI in patients with chronic thyroid orbitopathy. J Comput Assist Tomogr 29:115–120PubMedCrossRef Taoka T (2005) Evaluation of extraocular muscles using dynamic contrast enhanced MRI in patients with chronic thyroid orbitopathy. J Comput Assist Tomogr 29:115–120PubMedCrossRef
16.
Zurück zum Zitat Cakirer S (2004) Evaluation of extraocular muscles in the edematous phase of Graves ophthalmopathy on contrast-enhanced fat-suppressed magnetic resonance imaging. J Comput Assist Tomogr 28:80–86PubMedCrossRef Cakirer S (2004) Evaluation of extraocular muscles in the edematous phase of Graves ophthalmopathy on contrast-enhanced fat-suppressed magnetic resonance imaging. J Comput Assist Tomogr 28:80–86PubMedCrossRef
17.
Zurück zum Zitat Sepahdari AR, Aakalu V, Setabutr P, Shiehmorteza M, Naheedy JH, Mafee MF (2010) Indeterminate orbital masses at MR imaging. Radiology 256:554–564PubMedCrossRef Sepahdari AR, Aakalu V, Setabutr P, Shiehmorteza M, Naheedy JH, Mafee MF (2010) Indeterminate orbital masses at MR imaging. Radiology 256:554–564PubMedCrossRef
18.
Zurück zum Zitat Politi LS, Forghani R, Godi C et al (2010) Ocular adnexal lymphoma: diffusion-weighted MR Imaging for differential diagnosis and therapeutic monitoring. Radiology 256:565–574PubMedCrossRef Politi LS, Forghani R, Godi C et al (2010) Ocular adnexal lymphoma: diffusion-weighted MR Imaging for differential diagnosis and therapeutic monitoring. Radiology 256:565–574PubMedCrossRef
19.
Zurück zum Zitat Razek A, Elkhamary S, Mousa A (2011) Differentiation between benign and malignant orbital tumors at 3-T diffusion MR-imaging. Neuroradiology 53:517–522PubMedCrossRef Razek A, Elkhamary S, Mousa A (2011) Differentiation between benign and malignant orbital tumors at 3-T diffusion MR-imaging. Neuroradiology 53:517–522PubMedCrossRef
20.
Zurück zum Zitat Sepahdari AR, Kapur R, Aakalu VK, Villablanca JP, Mafee MF (2012) Diffusion-weighted imaging of malignant ocular masses: initial results and directions for further study. Am J Neuroradiol 33:314–319PubMedCrossRef Sepahdari AR, Kapur R, Aakalu VK, Villablanca JP, Mafee MF (2012) Diffusion-weighted imaging of malignant ocular masses: initial results and directions for further study. Am J Neuroradiol 33:314–319PubMedCrossRef
21.
Zurück zum Zitat Laurberg P, Berman DC, Bülow Pedersen I, Andersen S, Carlé A (2012) Incidence and clinical presentation of moderate to severe Graves' orbitopathy in a Danish population before and after iodine fortification of salt. J Clin Endocrinol Metab 97:2325–2332PubMedCentralPubMedCrossRef Laurberg P, Berman DC, Bülow Pedersen I, Andersen S, Carlé A (2012) Incidence and clinical presentation of moderate to severe Graves' orbitopathy in a Danish population before and after iodine fortification of salt. J Clin Endocrinol Metab 97:2325–2332PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Kirsch E, Kaim AH, Oliveira MGD, Gv A (2010) Correlation of signal intensity ratio on orbital MRI-TIRM and clinical activity score as a possible predictor of therapy response in Graves' orbitopathy-a pilot study at 1.5 T. Neuroradiology 52:91–97PubMedCrossRef Kirsch E, Kaim AH, Oliveira MGD, Gv A (2010) Correlation of signal intensity ratio on orbital MRI-TIRM and clinical activity score as a possible predictor of therapy response in Graves' orbitopathy-a pilot study at 1.5 T. Neuroradiology 52:91–97PubMedCrossRef
23.
Zurück zum Zitat Gonçalves AC, Silva LN, Gebrim EM, Monteiro ML (2012) Quantification of orbital apex crowding for screening of dysthyroid optic neuropathy using multidetector CT. Am J Neuroradiol 33:1602–1607PubMedCrossRef Gonçalves AC, Silva LN, Gebrim EM, Monteiro ML (2012) Quantification of orbital apex crowding for screening of dysthyroid optic neuropathy using multidetector CT. Am J Neuroradiol 33:1602–1607PubMedCrossRef
24.
Zurück zum Zitat Müller-Forell W, Kahaly GJ (2012) Neuroimaging of Graves' orbitopathy. Best Pract Res Clin Endocrinol Metab 26:259–271PubMedCrossRef Müller-Forell W, Kahaly GJ (2012) Neuroimaging of Graves' orbitopathy. Best Pract Res Clin Endocrinol Metab 26:259–271PubMedCrossRef
25.
Zurück zum Zitat Bijlsma WR (2006) Radiologic measurement of extraocular muscle volumes in patients with Graves' orbitopathy: a review and guideline. Orbit 25:83–91PubMedCrossRef Bijlsma WR (2006) Radiologic measurement of extraocular muscle volumes in patients with Graves' orbitopathy: a review and guideline. Orbit 25:83–91PubMedCrossRef
Metadaten
Titel
Magnetic resonance imaging with diffusion-weighted imaging in the evaluation of thyroid-associated orbitopathy: getting below the tip of the iceberg
verfasst von
Letterio Salvatore Politi
Claudia Godi
Gabriella Cammarata
Alessandro Ambrosi
Antonella Iadanza
Roberto Lanzi
Andrea Falini
Stefania Bianchi Marzoli
Publikationsdatum
01.05.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 5/2014
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-014-3103-3

Weitere Artikel der Ausgabe 5/2014

European Radiology 5/2014 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.